Related Experiment Video
Updated: May 8, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Statins and long-term survival after isolated valve surgery: the importance of valve type, position and procedure
Mark Pullan1, John Chalmers, Neeraj Mediratta
1Liverpool Heart and Chest Hospital, Liverpool, UK.
Insights
Statin therapy improves long-term survival after aortic valve replacement, particularly with biological valves. However, statins offer no survival benefit for mitral valve surgery patients.
Area of Science:
- Cardiovascular Surgery
- Pharmacology
- Clinical Outcomes Research
Background:
- Statin therapy is widely used for cardiovascular disease prevention.
- The impact of statins on long-term survival after isolated valve surgery requires further clarification.
- Previous studies have not consistently differentiated outcomes based on valve type, position, or surgical procedure.
Purpose of the Study:
- To determine if valve position, type, and surgical procedure influence the benefits of statin therapy on long-term survival.
- To investigate the association between statin use and survival outcomes in patients undergoing isolated single valve surgery.
Main Methods:
- Prospective analysis of a single-institution cardiac surgery database (n=5013).
- Statistical analyses included univariate, multivariate logistic and Cox regression, and propensity matching.
- Evaluation of statin therapy's association with survival, in-hospital mortality, length of stay, and postoperative enzyme release.
Main Results:
- Statin therapy was associated with improved long-term survival in all isolated valve surgery patients (P=0.03) and isolated aortic valve surgery (P=0.03).
- No survival benefit was observed for statin use in isolated mitral valve surgery (P=0.4).
- Cox regression and propensity matching confirmed statin benefits for aortic valve replacement (especially biological valves), reducing mortality, hospital stay, and enzyme release, but not for mitral valve procedures.
Conclusions:
- Statin therapy significantly improves long-term survival after isolated aortic valve replacement with a biological valve.
- Statin therapy demonstrated no survival benefit in patients undergoing mitral valve repair or mechanical aortic valve replacement.
- Further randomized trials are recommended to validate these findings regarding statin therapy in specific valve surgery populations.
Objectives:
To investigate whether valve position, type and procedure are important factors in determining the beneficial effects of statin therapy with regard to long-term survival in patients undergoing isolated single valve surgery.
Methods:
A prospective single-institution cardiac surgery database was analysed. Univariate, multivariate stepwise linear, logistic and Cox regression analysis and propensity matching were performed to identify if statins were associated with increased survival post-valve surgery.
Results:
Overall mortality was 3.4% (n = 172) for all cases, n = 5013. The median follow-up was 5.8 years. Kaplan-Meier survival analysis indicated that statin therapy was beneficial for all patients undergoing isolated valve surgery, n = 5013, P = 0.03 and isolated aortic valve surgery, n = 3220, P = 0.03, but not isolated mitral valve surgery n = 1793, P = 0.4. Cox regression analysis of the study cohort revealed that statin therapy was a significant factors determining long-term survival in the study cohort, postisolated aortic valve replacement and postisolated biological aortic valve replacement. Statins therapy was not associated with an increased long-term survival post-mitral valve replacement or repair. Propensity matching resulted in 1555 patients receiving statins being matched 1:1 with those not receiving statins. The results after propensity matching concurred with that of the Cox regression analyses, demonstrating that statin therapy was significantly associated with reduced in-hospital mortality, hospital length of stay and postoperative creatinine kinase, muscle-brain isoenzyme release.
Conclusions:
Previous publications have not distinguished valve type, position and repair as possible factors influencing statin-therapy outcomes. Statin therapy is associated with increased long-term survival postaortic valve replacement with a biological valve only. Statin therapy had no survival benefit in patients undergoing mitral valve repair or a mechanical valve replacement. A randomized trial is necessary to confirm or refute our findings.
Related Concept Videos
Mitral Stenosis III: Medical Management
Endocarditis III: Medical Management
Mitral Stenosis IV: Nursing Management
Mitral Valve Prolapse II: Assessment and Management
Aortic Regurgitation III: Medical Management
Mitral Valve Prolapse III: Nursing Management
